Practical approach for medical validation of therapeutic drug monitoring results

Articles in the same Issue

1. Frontmatter
2. Editorial
3. The way of prostate cancer diagnostics
4. Review
5. Statistical methods used in the calculation of geriatric reference intervals: a systematic review
6. Opinion Paper
7. The side effects of translational omics: overtesting, overdiagnosis, overtreatment
8. Genetics and Molecular Diagnostics
9. Rapid detection of non-deletional mutations causing α-thalassemia by multicolor melting curve analysis
10. General Clinical Chemistry and Laboratory Medicine
11. Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay
12. Long-term stability of glucose: 96-h study using Terumo Glycaemia tubes
13. Glucose is stable during prolonged storage in un-centrifuged Greiner tubes with liquid citrate buffer, but not in serum and NaF/KOx tubes
14. Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples
15. Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium
16. Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood
17. Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study
18. Comparison of functional fibrinogen (FF/CFF) and FIBTEM in surgical patients – a retrospective study
19. Reference Values and Biological Variations
20. Assessment of serum free light chain levels in healthy adults immediately after marathon running
21. Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients
22. Cancer Diagnostics
23. An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: a national scale study
24. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
25. Infectious Diseases
26. Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma
27. Evaluating the use of procalcitonin in an asymptomatic, HIV-infected antiretroviral therapy-naïve, South African cohort
28. Diabetes
29. Early prediction of gestational diabetes: a practical model combining clinical and biochemical markers
30. Letters to the Editors
31. Highly-trained dogs’ olfactory system for detecting biochemical recurrence following radical prostatectomy
32. More on the accuracy of the Architect enzymatic assay for hemoglobin A_1c and its traceability to the IFCC reference system
33. Assessing quality from an accuracy-based HbA_1c proficiency survey
34. HbG-Honolulu interferes with some cation-exchange HPLC HbA_1c assays
35. Between analyser differences in chloride measurements and thus anion gap cause different interpretations of the acid-base balance
36. Non-albumininuric proteinuria: a urinary tubular marker in the diagnosis of diabetic kidney disease
37. International Normalized Ratio (INR) testing: analytical and clinical performance of four point-of-care devices versus central laboratory instrumentation analysis
38. Genetic screening of the makorin ring finger 3 gene in girls with idiopathic central precocious puberty
39. Practical approach for medical validation of therapeutic drug monitoring results
40. Marked elevation of procalcitonin in a patient with a drug related infusion reaction to rituximab